Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: CARCINOMA, RENAL CELL - BLOOD , . Treffer: 11

2019

Vehabovic-Delic, A; Balic, M; Rossmann, C; Bauernhofer, T; Deutschmann, HA; Schoellnast, H Volume Computed Tomography Perfusion Imaging: Evaluation of the Significance in Oncologic Follow-up of Metastasizing Renal Cell Carcinoma in the Early Period of Targeted Therapy - Preliminary Results.
J Comput Assist Tomogr. 2019; 43(3):493-498
Web of Science PubMed FullText FullText_MUG

 

2017

Dalpiaz, O; Luef, T; Seles, M; Stotz, M; Stojakovic, T; Pummer, K; Zigeuner, R; Hutterer, GC; Pichler, M Critical evaluation of the potential prognostic value of the pretreatment-derived neutrophil-lymphocyte ratio under consideration of C-reactive protein levels in clear cell renal cell carcinoma.
Br J Cancer. 2017; 116(1):85-90 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2015

Bezan, A; Mrsic, E; Krieger, D; Stojakovic, T; Pummer, K; Zigeuner, R; Hutterer, GC; Pichler, M The Preoperative AST/ALT (De Ritis) Ratio Represents a Poor Prognostic Factor in a Cohort of Patients with Nonmetastatic Renal Cell Carcinoma.
J Urol. 2015; 194(1):30-35
Web of Science PubMed FullText FullText_MUG

 

Dalpiaz, O; Pichler, M; Mrsic, E; Reitz, D; Krieger, D; Venturino, L; Bezan, A; Stojakovic, T; Pummer, K; Zigeuner, R; Hutterer, GC Preoperative serum-gamma-glutamyltransferase (GGT) does not represent an independent prognostic factor in a European cohort of patients with non-metastatic renal cell carcinoma.
J Clin Pathol. 2015; 68(7):547-551
Web of Science PubMed FullText FullText_MUG

 

2013

Pichler, M; Hutterer, GC; Stoeckigt, C; Chromecki, TF; Stojakovic, T; Golbeck, S; Eberhard, K; Gerger, A; Mannweiler, S; Pummer, K; Zigeuner, R Validation of the pre-treatment neutrophil-lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients.
Br J Cancer. 2013; 108(4):901-907 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Pichler, M; Hutterer, GC; Stojakovic, T; Mannweiler, S; Pummer, K; Zigeuner, R High plasma fibrinogen level represents an independent negative prognostic factor regarding cancer-specific, metastasis-free, as well as overall survival in a European cohort of non-metastatic renal cell carcinoma patients.
Br J Cancer. 2013; 109(5):1123-1129 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2008

Zigeuner, R Editorial comment on: Lower plasma adiponectin levels are associated with larger tumor size and metastasis in clear-cell carcinoma of the kidney.
Eur Urol. 2008; 54(4): 873-874.
PubMed FullText FullText_MUG

 

2007

Karakiewicz, PI; Hutterer, GC; Trinh, QD; Jeldres, C; Perrotte, P; Gallina, A; Tostain, J; Patard, JJ C-reactive protein is an informative predictor of renal cell carcinoma-specific mortality: a European study of 313 patients.
Cancer. 2007; 110(6):1241-1247 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Schips, L; Dalpiaz, O; Lipsky, K; Langner, C; Rehak, P; Puerstner, P; Pummer, K; Zigeuner, R Serum levels of vascular endothelial growth factor (VEGF) and endostatin in renal cell carcinoma patients compared to a control group.
Eur Urol. 2007; 51(1): 168-173.
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1994

Pummer, K; Pürstner, P; Auner, HL; Stettner, H; Trummer, H; Penkoff, H; Rauchenwald, M Serum immunosuppressive acid protein predicts lymph node metastases in patients with renal cell carcinoma.
Br J Urol. 1994; 73(6):612-614
Web of Science PubMed FullText FullText_MUG

 

1992

Pummer, K; Wirnsberger, G; Pürstner, P; Stettner, H; Wandschneider, G False positive prostate specific antigen values in the sera of women with renal cell carcinoma.
J Urol. 1992; 148(1):21-23
Web of Science PubMed FullText FullText_MUG Google Scholar

 

© Med Uni Graz Impressum